Yukang Yuan

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

mBio

Immunology

EMBO reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Miao, Tingting Zhang, Mingcheng Guan, Qian Zhao, Renxia Zhang, Xuyi Liu, Tianrun Ma, Tengfei Ren, Zhijin Zheng, Wei He, Wanying Tian, Qun Cui, Xingyu Zhai, Yibo Zuo, Hong Zhu, Hui Zheng, Yukang Yuan
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1. mBio 15 (3) (2024)
Ying Miao, Tingting Zhang, Mingcheng Guan, Qian Zhao, Renxia Zhang, Xuyi Liu, Tianrun Ma, Tengfei Ren, Zhijin Zheng, Wei He, Wanying Tian, Qun Cui, Xingyu Zhai, Yibo Zuo, Hong Zhu, Hui Zheng, Yukang Yuan
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1. mBio 15 (3) (2024)
Ying Miao, Tingting Zhang, Mingcheng Guan, Qian Zhao, Renxia Zhang, Xuyi Liu, Tianrun Ma, Tengfei Ren, Zhijin Zheng, Wei He, Wanying Tian, Qun Cui, Xingyu Zhai, Yibo Zuo, Hong Zhu, Hui Zheng, Yukang Yuan
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1. mBio (2024)
Ying Miao, Tingting Zhang, Mingcheng Guan, Qian Zhao, Renxia Zhang, Xuyi Liu, Tianrun Ma, Tengfei Ren, Zhijin Zheng, Wei He, Wanying Tian, Qun Cui, Xingyu Zhai, Yibo Zuo, Hong Zhu, Hui Zheng, Yukang Yuan
DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1. mBio 15 (3) (2024)
Caixia Qiao, Fan Huang, Jiuyi He, Qiuyu Wu, Zhijin Zheng, Tingting Zhang, Ying Miao, Yukang Yuan, Xiangjie Chen, Qian Du, Yang Xu, Depei Wu, Zhengyuan Yu, Hui Zheng
Ceftazidime reduces cellular Skp2 to promote type-I interferon activity. Immunology (2023)
Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, Xinhua Cao, Ying Miao, Yukang Yuan, Yanli Liu, Feng Ma, Jianfeng Dai, Sheng Tian, Qiang Ding, Hui Zheng
Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection. EMBO reports (2023)
Xiangjie Chen, Qian Zhao, Ying Xu, Qiuyu Wu, Renxia Zhang, Qian Du, Ying Miao, Yibo Zuo, Hong-Guang Zhang, Fan Huang, Tengfei Ren, Jiuyi He, Caixia Qiao, Yue Li, Shifeng Li, Yang Xu, Depei Wu, Zhengyuan Yu, Haitao Lv, Jun Wang, Hui Zheng, Yukang Yuan
E3 ubiquitin ligase MID1 ubiquitinates and degrades type-I interferon receptor 2. Immunology 167 (3) (2022)

Yukang Yuan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yukang Yuan